Search research articles
Contact Us
Filters
Showing results (461-470 of 475) with videos related to
Page
of 48
Sort By:
Addiction Science & Clinical Practice
|
October 23, 2025
Dissemination of an evidence-based motivational interviewing brief intervention for substance use disorders to HIV service organizations across the United States: protocol for a national-level cluster-randomized adaptive parallel-groups superiority experiment
Hannah K Knudsen, Heather J Gotham, Elizabeth Solinger, et al.
British Journal of Clinical Pharmacology
|
January 27, 2015
Observational infant exploratory [(14)C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis
Colin R Garner, Kevin B Park, Neil S French, et al.
Contemporary Clinical Trials
|
August 2, 2020
Positive Health Check evaluation: A type 1 hybrid design randomized trial to decrease HIV viral loads in patients seen in HIV primary care
Megan A Lewis, Camilla Harshbarger, Carla Bann, et al.
Plos One
|
November 19, 2011
Role of SPI-1 secreted effectors in acute bovine response to Salmonella enterica Serovar Typhimurium: a systems biology analysis approach
Sara D Lawhon, Sangeeta Khare, Carlos A Rossetti, et al.
Drug and Alcohol Dependence
|
May 13, 2021
Corrigendum to "Model and approach for assessing implementation context and fidelity in the HEALing Communities Study" [Drug Alcohol Depend. 217 (2020) 108330]
Hannah K Knudsen, Mari-Lynn Drainoni, Louisa Gilbert, et al.
Drug and Alcohol Dependence
|
October 21, 2020
Model and approach for assessing implementation context and fidelity in the HEALing Communities Study
Hannah K Knudsen, Mari-Lynn Drainoni, Louisa Gilbert, et al.
Plos One
|
March 11, 2011
A survey of new temperature-sensitive, embryonic-lethal mutations in C. elegans: 24 alleles of thirteen genes
Sean M O'Rourke, Clayton Carter, Luke Carter, et al.
The Journal of Infectious Diseases
|
March 18, 2000
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators
D L Birx, L D Loomis-Price, N Aronson, et al.
Neuron
|
March 6, 2015
Transgenic mice for intersectional targeting of neural sensors and effectors with high specificity and performance
Linda Madisen, Aleena R Garner, Daisuke Shimaoka, et al.
Cell Reports
|
February 23, 2022
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer
Stephen Tang, Vidyalakshmi Sethunath, Nebiyou Y Metaferia, et al.
Page
of 48
Search research articles
Search
Showing results (461-470 of 475) with videos related to
Sort By:
Page
of 48
Addiction Science & Clinical Practice
|
October 23, 2025
Dissemination of an evidence-based motivational interviewing brief intervention for substance use disorders to HIV service organizations across the United States: protocol for a national-level cluster-randomized adaptive parallel-groups superiority experiment
Hannah K Knudsen, Heather J Gotham, Elizabeth Solinger, et al.
British Journal of Clinical Pharmacology
|
January 27, 2015
Observational infant exploratory [(14)C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis
Colin R Garner, Kevin B Park, Neil S French, et al.
Contemporary Clinical Trials
|
August 2, 2020
Positive Health Check evaluation: A type 1 hybrid design randomized trial to decrease HIV viral loads in patients seen in HIV primary care
Megan A Lewis, Camilla Harshbarger, Carla Bann, et al.
Plos One
|
November 19, 2011
Role of SPI-1 secreted effectors in acute bovine response to Salmonella enterica Serovar Typhimurium: a systems biology analysis approach
Sara D Lawhon, Sangeeta Khare, Carlos A Rossetti, et al.
Drug and Alcohol Dependence
|
May 13, 2021
Corrigendum to "Model and approach for assessing implementation context and fidelity in the HEALing Communities Study" [Drug Alcohol Depend. 217 (2020) 108330]
Hannah K Knudsen, Mari-Lynn Drainoni, Louisa Gilbert, et al.
Drug and Alcohol Dependence
|
October 21, 2020
Model and approach for assessing implementation context and fidelity in the HEALing Communities Study
Hannah K Knudsen, Mari-Lynn Drainoni, Louisa Gilbert, et al.
Plos One
|
March 11, 2011
A survey of new temperature-sensitive, embryonic-lethal mutations in C. elegans: 24 alleles of thirteen genes
Sean M O'Rourke, Clayton Carter, Luke Carter, et al.
The Journal of Infectious Diseases
|
March 18, 2000
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators
D L Birx, L D Loomis-Price, N Aronson, et al.
Neuron
|
March 6, 2015
Transgenic mice for intersectional targeting of neural sensors and effectors with high specificity and performance
Linda Madisen, Aleena R Garner, Daisuke Shimaoka, et al.
Cell Reports
|
February 23, 2022
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer
Stephen Tang, Vidyalakshmi Sethunath, Nebiyou Y Metaferia, et al.
Page
of 48